Selected article for: "AAT short peptide and nitric oxide"
Author: Su, Junhui; Chang, Cui; Xiang, Qi; Zhou, Zhi-Wei; Luo, Rong; Yang, Lun; He, Zhi-Xu; Yang, Hongtu; Li, Jianan; Bei, Yu; Xu, Jinmei; Zhang, Minjing; Zhang, Qihao; Su, Zhijian; Huang, Yadong; Pang, Jiyan; Zhou, Shu-Feng
Title: Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study
  • Document date: 2014_12_12
    • ID: y14atmnh_70
    Snippet: Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin, and plasminogen activator. The aberrant form inhibits insulin-induced nitric oxide synthesis in platelets, decreases coagulation time, and has proteolytic activity against insulin and plasmin. Short peptide from AAT is a reversible chymotrypsin inhibitor. It also inhibits elastas.....
    Document: Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin, and plasminogen activator. The aberrant form inhibits insulin-induced nitric oxide synthesis in platelets, decreases coagulation time, and has proteolytic activity against insulin and plasmin. Short peptide from AAT is a reversible chymotrypsin inhibitor. It also inhibits elastase, but not trypsin. Its major physiological function is the protection of the lower respiratory tract against proteolytic destruction by human leukocyte elastase. showing the greater ability to mobilize cytoplasmic calcium in comparison to isoform 1. Required in brain development and mature brain function with important roles in the regulation of axon growth, axon guidance, and neurite extension. Blocks axon out growth and attraction induced by NTN1 by phosphorylating its receptor DDC.

    Search related documents:
    Co phrase search for related documents
    • AAT short peptide and chymotrypsin inhibitor: 1
    • AAT short peptide and coagulation time: 1
    • AAT short peptide and human leukocyte elastase: 1
    • AAT short peptide and major physiological function: 1
    • AAT short peptide and moderate affinity: 1
    • AAT short peptide and nitric oxide: 1
    • AAT short peptide and nitric oxide synthesis: 1
    • AAT short peptide and physiological function: 1
    • AAT short peptide and plasmin insulin: 1
    • AAT short peptide and plasmin insulin proteolytic activity: 1
    • AAT short peptide and plasminogen activator: 1
    • AAT short peptide and primary target: 1
    • AAT short peptide and proteolytic activity: 1
    • AAT short peptide and proteolytic destruction: 1
    • AAT short peptide and proteolytic destruction respiratory tract: 1
    • AAT short peptide and respiratory tract: 1
    • AAT short peptide and reversible chymotrypsin inhibitor: 1
    • AAT short peptide and short peptide: 1
    • AAT short peptide and thrombin plasmin moderate affinity: 1